Augmenting HER2 IHC Assessment, Including HER2 Ultralow Scoring, in Breast Cancer with AI Support: A Multinational Observational Study

October 21, 2025

•

7 min read

Share this post

This international multicenter study of AI assistance reduced reading time 1000+ cases demonstrates the value of per case and improved pathologist.

AI-assisted HER2 IHC interpretation for concordance and accuracy, pathology routine particularly at the HER2 null, ultralow and low ranges.

Integrating AI can thus help optimize treatment decisions for patients with HER2 low and ultralow.

‍

Live Publication Link

Share this article

Related reading

ihc

8 min read

Enhancing HER2 IHC Interpretation in Breast Cancer with AI Assistance: Focus on Ultralow Expression in a Multicenter Study across Asia

Emerging therapies for HER2-low and -ultralow breast cancer emphasize the need for precise and consistent HER2 IHC scoring. However, interpretation remains challenging due to staining variability and subjective thresholds. AI tools may improve diagnostic accuracy and reproducibility, yet real-world data across multiple centers - especially for HER2-ultralow expression - to date is sparse.

ihc

8 min read

Quantitative and qualitative evaluation of an AI-assistance software for PD-L1 TPS assessment in non-small cell lung cancer (NSCLC)

In summary, the AI software investigated was found to increase both accuracy and interobserver agreement of pathologists in PD-L1 NSCLC TPS scoring and was reported to be helpful and user-friendly for application in a routine diagnostic workflow.

ihc

8 min read

Augmenting HER2 IHC Assessment, Including HER2 Ultralow Scoring, in Breast Cancer with AI Support: A Multinational Observational Study

The emergence of novel therapies targeting low and ultralow HER2 expression in breast cancer stresses the need for accurate, reproducible HER2 immunohistochemistry (IHC) assessment.

ihc

8 min read

Al-based accurate PD-L1 IHC assessment in non-small cell lung cancer across multiple sites and scanners

Using challenging validation data from three institutions and four scanners, ROI scoring with the support of our Al. PD-L1 quantifier showed high agreement with pathologists, while significantly reducing assessment time.

ihc

8 min read

Poster HER2-low presented at ASCO2023

Our #ASCO2023 poster on HER2-low was selected for oral presentation by session chair Prof. David Rimm (Yale University School of Medicine). In his discussion he highlighted AI as an essential means to score HER2 in the future.

ihc

8 min read

Mindpeak’s PD-L1 CPS AI to identify more patients for checkpoint therapy in gastric cancer at pathologist-level interobserver concordance

Our study, presented at ASCO 2024, investigated the use of AI-based software to assess PD-L1 expression in gastric cancer. The AI demonstrated a higher agreement with pathologists than pathologists with each other, while classifying more patients as eligible for immunotherapy.

ihc

8 min read

Advancing HER2 Diagnostics with AI – Insights from Our Collaboration with AstraZeneca

At ESMO2025, Mindpeak and AstraZeneca delivered new evidence on how AI can advance precision oncology – sharing results from a multinational study validating AI-assisted HER2 immunohistochemistry (IHC) scoring across 12 academic centres and more than 1,000 breast cancer cases.

Elevate Your Diagnostic Workflow with Clinical-Grade AI

Whether you are looking to scale your lab’s capacity with our existing high-performance IHC suites or require a custom AI solution tailored to your specific diagnostic workflow, Mindpeak is your dedicated partner in precision pathology.

Our technology is already trusted in over 40 labs globally and features the most comprehensive integration ecosystem in the industry, with 18+ clinical IMS partner integrations to ensure a "plug-and-play" experience with your existing hardware. Stop manual reader variability and start delivering reproducible, algorithm-driven results for every patient

Join the future of digital pathology with our diagnostic AI platform.

Consult

Book a Demo

Two angled computer monitors display scientific data with colorful heatmaps and tissue images on a purple background.